We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$49B
AUM Growth
-$8.48B
Cap. Flow
+$10.7B
Cap. Flow %
21.85%
Top 10 Hldgs %
14.83%
Holding
3,035
New
269
Increased
1,096
Reduced
1,170
Closed
157

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$94M
2
CTVA icon
Corteva
CTVA
+$81.7M
3
PFE icon
Pfizer
PFE
+$77.5M
4
WRK
WestRock Company
WRK
+$67.1M
5
WMT icon
Walmart Inc
WMT
+$57.2M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.99%
3 Healthcare 13.6%
4 Real Estate 9.33%
5 Consumer Discretionary 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WGO icon
2701
Winnebago Industries
WGO
$920M
$19K ﹤0.01%
395
-1,105
-74% -$57.1K
XGN icon
2702
Exagen
XGN
$166M
$19K ﹤0.01%
3,439
CHMG icon
2703
Chemung Financial Corp
CHMG
$394M
$18K ﹤0.01%
389
-30
-7% -$1.36K
FOLD
2704
DELISTED
Amicus Therapeutics
FOLD
$18K ﹤0.01%
1,726
-944
-35% -$7.77K
GH icon
2705
Guardant Health
GH
$22.4B
$18K ﹤0.01%
458
PHR icon
2706
Phreesia
PHR
$775M
$18K ﹤0.01%
748
-6,752
-90% -$149K
PING
2707
DELISTED
Ping Identity Holding Corp.
PING
$18K ﹤0.01%
1,012
-45,851
-98% -$1.02M
ONTO icon
2708
Onto Innovation
ONTO
$15.3B
$17K ﹤0.01%
254
-97
-28% -$7.18K
SLDB icon
2709
Solid Biosciences
SLDB
$943M
$17K ﹤0.01%
1,885
CVAC
2710
DELISTED
CureVac
CVAC
$16K ﹤0.01%
+1,205
New +$19.9K
LXP icon
2711
LXP Industrial Trust
LXP
$3.58B
$16K ﹤0.01%
314
URGN icon
2712
UroGen Pharma
URGN
$2.3B
$16K ﹤0.01%
1,962
VBIV
2713
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$16K ﹤0.01%
686
AFMD
2714
DELISTED
Affimed
AFMD
$15K ﹤0.01%
566
-2,600
-82% -$89K
BNL icon
2715
Broadstone Net Lease
BNL
$3.98B
$15K ﹤0.01%
767
KAI icon
2716
Kadant
KAI
$4B
$15K ﹤0.01%
85
-52
-38% -$9.69K
LBRDA icon
2717
Liberty Broadband Class A
LBRDA
$5.29B
$15K ﹤0.01%
140
-3,042
-96% -$357K
LCII icon
2718
LCI Industries
LCII
$2.62B
$15K ﹤0.01%
138
-92
-40% -$10.1K
DMTK
2719
DELISTED
DermTech, Inc. Common Stock
DMTK
$15K ﹤0.01%
2,734
-12,113
-82% -$99.2K
SURF
2720
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$15K ﹤0.01%
9,240
ALBO
2721
DELISTED
Albireo Pharma Inc
ALBO
$15K ﹤0.01%
776
-462
-37% -$12.2K
AEIS icon
2722
Advanced Energy
AEIS
$13B
$14K ﹤0.01%
193
-120
-38% -$9.28K
BYRN icon
2723
Byrna Technologies
BYRN
$106M
$14K ﹤0.01%
+1,664
New +$12.7K
CCRD
2724
DELISTED
CoreCard
CCRD
$14K ﹤0.01%
+609
New +$14.4K
FLGT icon
2725
Fulgent Genetics
FLGT
$528M
$14K ﹤0.01%
270
-4,312
-94% -$237K

Similar funds

Russell Investments Group's Q2 2022 Portfolio in Review

As of Q2 2022, Russell Investments Group held 3,035 positions worth $49B, down 15% from $57.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Russell Investments Group deployed $10.7B of net new capital in Q2 2022, opening 269 new positions and adding to 1,096 existing holdings. Its largest new stake was Bank of America Series L: 6,020,000 shares worth $7.25M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AT&T, an estimated $94M trimmed.

  • Russell Investments Group's largest Q2 2022 buy was Bank of America Series L: 6,020,000 shares worth $7.25M.
  • Russell Investments Group added most to Realty Income in Q2 2022, an estimated $93.9M increase.
  • Russell Investments Group's biggest Q2 2022 reduction was AT&T, cutting an estimated $94M.
  • Russell Investments Group fully exited Cornerstone Building Brands, Inc. in Q2 2022, selling an estimated $34.9M.
  • Russell Investments Group's ten largest holdings make up 15% of its $49B portfolio in Q2 2022.
  • Russell Investments Group opened 269 new positions and closed 157 in Q2 2022.
  • Russell Investments Group's portfolio value fell 15% quarter-over-quarter to $49B.

Based on Russell Investments Group's 13F filing for Q2 2022, filed 29 Jul 2022.